Linde | LIN - Cash And Equivalent


Linde reported $3.96B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Air Products & Chemicals USD 951M 75.4M Mar/2026
Acerinox EUR 969.89M 208.11M Dec/2025
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 1.62B 66M Dec/2025
Arkema EUR 2.19B 235M Dec/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 6.67B 774M Dec/2025
Corteva USD 1.96B 2.56B Mar/2026
Covestro EUR 648M 44M Dec/2025
Dow USD 4.11B 294M Mar/2026
Dupont De Nemours USD 710M 5M Mar/2026
Henkel EUR 2.71B 163M Dec/2025
Huntsman USD 369M 60M Mar/2026
Johnson Matthey GBP 542M 49M Jun/2024
Linde USD 3.96B 1.1B Mar/2026
LyondellBasell Industries USD 2.64B 814M Mar/2026
Merck EUR 2.33B 77M Dec/2025
PPG Industries USD 1.57B 590M Mar/2026
Sherwin-Williams USD 216.9M 9.7M Mar/2026
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 486M 50M Mar/2026
Umicore EUR 1.56B 450.17M Dec/2025
Westlake Chemical USD 2.27B 453M Mar/2026